The activation of Caspase-1 exists in the brain of Huntington's disease (HD) patients and in HD mouse models, and the inhibition of caspase-1 in HD mouse models can slow down the progression of the disease (Ona et al., 1999; Paldino et al., 2020). Here, CASP1 is linked to juvenile Huntington disease.